Buy Immutep Stock | PBMD Stock Price & Latest News | Public
PBMD

Immutep

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About PBMD

    Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$93,64M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.10
    1 Year Low$0.53
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app